ReVision Optics Announces First U.S. Commercial Cases of Raindrop Near Vision Inlay

By Staff
Monday, September 5, 2016 12:27 AM LAKE FOREST, Calif.—ReVision Optics announced the U.S. commercial launch of its Raindrop Near Vision Inlay. The launch plan calls for the company’s direct field force to focus on sites that participated in the U.S. IDE clinical trial, followed by a more broad-based expansion.

Presbia Acquires Comprehensive Patent Portfolio for the Presbia Flexivue Microlens

By Staff
Wednesday, August 24, 2016 12:18 AM DUBLIN, Ireland—Presbia PLC (NASDAQ: LENS) announced that its wholly-owned subsidiary, Presbia Ireland, Ltd. recently completed the purchase of the assets of Switzerland-based Neoptics AG, including its intellectual property portfolio for an aggregate purchase price of $1.5 million.

ReVision Optics Secures $10 Million Credit Facility

By Staff
Monday, August 22, 2016 12:23 AM LAKE FOREST, Calif. & SAN DIEGO—ReVision Optics (RVO) has secured a $10 million credit facility from Square 1 Bank, a division of Pacific Western Bank. RVO announced receipt of U.S. Food and Drug Administration (FDA) approval for its Raindrop Near Vision Inlay for the surgical correction of presbyopia on June 29, 2016. Proceeds from the credit facility will be used for working capital purposes including commercial operations, the company said.

ReVision Optics Names Dr. Nick J. Manesis Vice President of R&D

By Staff
Monday, August 15, 2016 12:21 AM LAKE FOREST, Calif.—ReVision Optics, maker of the Raindrop Near Vision Inlay, has named Nick J. Manesis, PhD as vice president of R&D. Dr. Manesis brings to RVO nearly 30 years of materials research and development experience, including at the leading ophthalmic companies Allergan and CooperVision.

Allergan 2Q Net Revenue Climbs to $3.7 Billion

By Staff
Wednesday, August 10, 2016 12:23 AM DUBLIN, Ireland—Allergan plc (NYSE: AGN) reported total net revenues of $3.7 billion for the second quarter ended June 30, 2016, a 2 percent increase versus the prior year quarter.

Bascom Palmer Launches Master’s Program in Vision Science and Investigative Ophthalmology

By Staff
Friday, August 5, 2016 12:21 AM MIAMI—Bascom Palmer Eye Institute is launching the world’s first master’s degree in Vision Science and Investigative Ophthalmology (MVSIO). The new program offers comprehensive training in ophthalmic translational research, problem-based learning and management.

Dr. Perry Rosenthal, Pioneering Ophthalmologist, to Receive 2016 Max Schapero Memorial Lecture Award

By Staff
Friday, August 5, 2016 12:18 AM CHESTNUT HILL, Mass.—Dr. Perry Rosenthal, a pioneering Boston ophthalmologist, has received the 2016 Max Schapero Memorial Lecture Award, the Boston EyePain Foundation announced. The award will officially be presented to Dr. Rosenthal at the Section's Awards Program in Anaheim, California on Nov. 9, 2016.

VisionWeb Offers Webinar Series on EHR Coaching to Enhance Patient Care

By Staff
Wednesday, August 3, 2016 12:24 AM AUSTIN, Texas—Ian Lane, OD, of VisionWeb will host a 4-part webinar series that will walk ECPs through various condition-based patient encounters common in most practices.

CenterVue Receives 501(k) Clearance from FDA for Fixation Training Module

By Staff
Wednesday, August 3, 2016 12:18 AM FREMONT, Calif. and PADOVA, Italy—CenterVue has received 510(k) clearance from the U.S. Food and Drug Administration for fixation training for its MAIA platform, a technology designed to help patients rehabilitate from vision loss using audio feedback.

James Mazzo to Head Zeiss Meditec’s Newly Consolidated Ophthalmology Unit

By Staff
Friday, July 29, 2016 12:24 AM JENA, Germany—James Mazzo will join Carl Zeiss Meditec as global president of ophthalmology with responsibility for the company’s new strategic business unit ophthalmology as well as Carl Zeiss Meditec's U.S. sales and service center.

AcuFocus Appoints Alan Waterhouse President and COO; William Link, PhD Becomes Chairman of the Board

By Staff
Friday, July 29, 2016 12:21 AM IRVINE, Calif.—AcuFocus, developer of the Kamra corneal inlay and IC-8 IOL, announced that Alan Waterhouse has been appointed president and chief operating officer (COO) and William Link, PhD, has joined the company as chairman of the board.

Second Sight Announces Positive Five-Year Data from Argus II Retinal Prosthesis System

By Staff
Monday, July 25, 2016 12:21 AM SYLMAR, Calif.—Second Sight Medical Products announced that a five-year study of patients who have the Argus II artificial retina implant has yielded positive results.

Valeant’s New Glaucoma Drug Raises No Safety or Efficacy Concerns With FDA

By Staff
Monday, July 25, 2016 12:18 AM LAVAL, Quebec—Valeant Pharmaceuticals International (NYSE: VRX and TSX: VRX) announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for latanoprostene bunod ophthalmic solution, 0.024 percent, an intraocular pressure lowering single-agent eye drop for patients with open angle glaucoma or ocular hypertension.

FDA Approves Raindrop Near Vision Inlay for Presbyopia Correction

By Staff
Friday, July 1, 2016 12:24 AM WASHINGTON, D.C.—The U.S. Food and Drug Administration has approved the Raindrop Near Vision Inlay, a device implanted in the cornea of one eye to improve near vision in certain patients with presbyopia.

Prevent Blindness Honors Rajeev S. Ramchandran, MD, With Joanne Angle Investigator Award

By Staff
Monday, June 27, 2016 12:21 AM CHICAGO—Prevent Blindness, has selected Rajeev S. Ramchandran, MD, MBA, associate professor of Ophthalmology, University of Rochester School of Medicine and Dentistry, as the honoree of the 13th annual 2016 Joanne Angle Investigator Award.
Loading...